chenodeoxycholic acid has been researched along with Weight Loss in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Behling, C; Chalasani, N; Dasarathy, S; Diehl, AM; Kleiner, D; Kowdley, K; Lavine, J; Loomba, R; Middleton, M; Neuschwander-Tetri, BA; Sanyal, A; Sirlin, C; Terrault, N; Tonascia, J; Van Natta, M | 1 |
| Aguilera, V; Ampuero, J; Bellido, F; Romero-Gómez, M; Sánchez-Torrijos, Y | 1 |
| Chalasani, N; Gill, RM; Hameed, B; Hoofnagle, JH; Loomba, R; Terrault, NA; Van Natta, ML | 1 |
| Abdelmalek, MF; Brunt, EM; Chalasani, N; Clark, JM; Dasarathy, S; Diehl, AM; Doo, E; Hameed, B; Kleiner, DE; Kowdley, KV; Lavine, JE; Loomba, R; McCullough, A; Neuschwander-Tetri, BA; Sanyal, AJ; Terrault, N; Tonascia, J; Van Natta, ML | 1 |
| Dufour, JF; Perazzo, H | 1 |
| Aldini, R; Bazzoli, F; Festi, D; Grigolo, B; Mazzella, G; Roda, A; Roda, E; Ronchi, M; Simoni, P; Villanova, N | 1 |
2 review(s) available for chenodeoxycholic acid and Weight Loss
| Article | Year |
|---|---|
New therapeutic perspectives in non-alcoholic steatohepatitis.
Topics: Bariatric Surgery; Chenodeoxycholic Acid; Clinical Trials as Topic; Combined Modality Therapy; Diet, Mediterranean; Dipeptidyl-Peptidase IV Inhibitors; Disease Management; Dyslipidemias; Endoscopy; Exercise Therapy; Gastrointestinal Microbiome; Glucagon-Like Peptide-1 Receptor; Humans; Insulin Resistance; MAP Kinase Kinase Kinase 5; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity, Abdominal; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Weight Loss | 2018 |
The therapeutic landscape of non-alcoholic steatohepatitis.
Topics: Antioxidants; Chalcones; Chenodeoxycholic Acid; Disease Progression; Humans; Hypoglycemic Agents; Insulin Resistance; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Pioglitazone; Propionates; Randomized Controlled Trials as Topic; Thiazolidinediones; Vitamin E; Weight Loss | 2017 |
4 trial(s) available for chenodeoxycholic acid and Weight Loss
| Article | Year |
|---|---|
Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH.
Topics: Adipose Tissue; Adult; Aged; Chenodeoxycholic Acid; Double-Blind Method; Female; Humans; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Protons; Weight Loss | 2020 |
Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis.
Topics: Adult; Alkaline Phosphatase; Biopsy; Body Weight; Chenodeoxycholic Acid; Cholesterol, LDL; Double-Blind Method; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Treatment Outcome; Weight Loss | 2018 |
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
Topics: Administration, Oral; Chenodeoxycholic Acid; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Weight Loss | 2015 |
Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
Topics: Adolescent; Adult; Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholesterol; Drug Evaluation; Female; Humans; Male; Middle Aged; Obesity; Phospholipids; Ursodeoxycholic Acid; Weight Loss | 1991 |